% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sartorius:136511,
author = {Sartorius, Tina and Lutz, Stefan Z and Hoene, Miriam and
Waak, Jens and Peter, Andreas and Weigert, Cora and
Rammensee, Hans-Georg and Kahle, Philipp J and Häring,
Hans-Ulrich and Hennige, Anita M},
title = {{T}oll-like receptors 2 and 4 impair insulin-mediated brain
activity by interleukin-6 and osteopontin and alter sleep
architecture.},
journal = {The FASEB journal},
volume = {26},
number = {5},
issn = {0892-6638},
address = {Bethesda, Md.},
publisher = {FASEB},
reportid = {DZNE-2020-02833},
pages = {1799-1809},
year = {2012},
abstract = {Impaired insulin action in the brain represents an early
step in the progression toward type 2 diabetes, and elevated
levels of saturated free fatty acids are known to impair
insulin action in prediabetic subjects. One potential
mediator that links fatty acids to inflammation and insulin
resistance is the Toll-like receptor (TLR) family.
Therefore, C3H/HeJ/TLR2-KO (TLR2/4-deficient) mice were fed
a high-fat diet (HFD), and insulin action in the brain as
well as cortical and locomotor activity was analyzed by
using telemetric implants. TLR2/4-deficient mice were
protected from HFD-induced glucose intolerance and insulin
resistance in the brain and displayed an improvement in
cortical and locomotor activity that was not observed in
C3H/HeJ mice. Sleep recordings revealed a $42\%$ increase in
rapid eye movement sleep in the deficient mice during
daytime, and these mice spent $41\%$ more time awake during
the night period. Treatment of control mice with a
neutralizing IL-6 antibody improved insulin action in the
brain as well as cortical activity and diminished
osteopontin protein to levels of the TLR2/4-deficient mice.
Together, our data suggest that the lack of functional
TLR2/4 protects mice from a fat-mediated impairment in
insulin action, brain activity, locomotion, and sleep
architecture by an IL-6/osteopontin-dependent mechanism.},
keywords = {Animals / Astrocytes: metabolism / Brain: physiology /
Cells, Cultured / Electroencephalography / Glucose Tolerance
Test / Insulin: physiology / Insulin Resistance /
Interleukin-6: immunology / Interleukin-6: physiology /
Locomotion / Mice / Mice, Inbred C3H / Mice, Knockout /
Osteopontin: physiology / Phosphorylation / Proto-Oncogene
Proteins c-akt: metabolism / Real-Time Polymerase Chain
Reaction / Sleep / Toll-Like Receptor 2: genetics /
Toll-Like Receptor 2: physiology / Toll-Like Receptor 4:
genetics / Toll-Like Receptor 4: physiology / Insulin (NLM
Chemicals) / Interleukin-6 (NLM Chemicals) / Tlr2 protein,
mouse (NLM Chemicals) / Tlr4 protein, mouse (NLM Chemicals)
/ Toll-Like Receptor 2 (NLM Chemicals) / Toll-Like Receptor
4 (NLM Chemicals) / Osteopontin (NLM Chemicals) /
Proto-Oncogene Proteins c-akt (NLM Chemicals)},
cin = {AG Kahle 2},
ddc = {570},
cid = {I:(DE-2719)1210000-4},
pnm = {345 - Population Studies and Genetics (POF3-345)},
pid = {G:(DE-HGF)POF3-345},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:22278939},
doi = {10.1096/fj.11-191023},
url = {https://pub.dzne.de/record/136511},
}